The company’s earnings declined across all parameters — net profit, revenue, EBITDA and margin.
The company’s net profit declined 59.8% to ₹40.3 crore in the fourth quarter from ₹100.2 crore in the previous year.
Its revenue was down 1% at ₹2,066 crore from ₹2,088 crore in the fourth quarter of the previous fiscal.
Its earnings before interest, tax, depreciation and amortization (EBITDA) declined 18.4% to ₹242.8 crore from ₹297.7 crore in the previous year.
The company’s margins contracted to 11.8% from 14.3% in the year-ago period.
The company in its investor presentation stated that its Nanovace Pilot Plant at Palej is ready to go live. It said the plant is fully equipped and ready for commissioning and the operations are expected to commence in the coming weeks.
For the financial year 2027, the company stated that there are near-term headwinds, but it is building strong momentum for volume growth and margin expansion.
It stated that the upward factors for FY27 are — India-US tariff reduction and EU trade deal, higher industry utilization levels, potential resolution of geopolitical conflicts, focus on Specialty and VAP and cost and efficiency optimisation.
Shares of PCBL Chemical Ltd. ended 3.4% lower at ₹288.62 on Thursday. The stock has gained 12% in the past month and has declined 2.5% this year, so far.
Also Read: Cholamandalam Investment Q4 profit jumps 29%, asset quality improves
